Trials / Completed
CompletedNCT00537563
AMS VS MOXI Ketek vs Avelox in AMS
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 351 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Clinical efficacy between telithromycin and moxifloxacin at the post-therapy/test of cure visit, and to assess the safety of telithromycin given once daily for 5 days vs moxifloxacin given once daily for 10 days in the treatment of subjects with AMS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Telithromycin |
Timeline
- Start date
- 2002-12-01
- Primary completion
- 2003-09-01
- Completion
- 2003-09-01
- First posted
- 2007-10-01
- Last updated
- 2012-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00537563. Inclusion in this directory is not an endorsement.